Developer of therapies in areas of unmet medical need in Cardiovascular, Infectious Disease, Respiratory, Inflammatory and Autoimmune diseases. The company is dedicated to the research, development and commercialization of innovative medicines in areas of unmet medical need. It is based on cutting-edge new drug development ideas and its own medicinal chemistry and CMC strengths, together with internal/external clinical development and regulatory expertise, the company devotes its resources towards identifying and progressing innovative NCEs with known mechanisms of action in validated targets for the treatment of patients with unmet medical needs in cardio-renal, infectious disease, respiratory, inflammatory and autoimmune diseases.